Page last updated: 2024-09-05

technetium tc 99m pentetate and (dtpa-phe(1))-octreotide

technetium tc 99m pentetate has been researched along with (dtpa-phe(1))-octreotide in 1 studies

Compound Research Comparison

Studies
(technetium tc 99m pentetate)
Trials
(technetium tc 99m pentetate)
Recent Studies (post-2010)
(technetium tc 99m pentetate)
Studies
((dtpa-phe(1))-octreotide)
Trials
((dtpa-phe(1))-octreotide)
Recent Studies (post-2010) ((dtpa-phe(1))-octreotide)
3,336275394268346

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barth, A; Geiger, L; Godoy, N; Haldemann, AR; Markwalder, RV; Reubi, JC; Rösler, H; Seiler, RW; Sulzer, M; Waser, B1

Other Studies

1 other study(ies) available for technetium tc 99m pentetate and (dtpa-phe(1))-octreotide

ArticleYear
Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:3

    Topics: Adolescent; Adult; Aged; Autoradiography; Blood-Brain Barrier; Brain Neoplasms; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Octreotide; Pentetic Acid; Radionuclide Imaging; Receptors, Somatostatin; Technetium Tc 99m Pentetate

1995